Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(17%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
67%
Ph phase_4
2
33%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Other(2)

Detailed Status

Completed3
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (33.3%)
N/A4 (66.7%)

Trials by Status

recruiting117%
unknown233%
completed350%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_4

Ticagrelor De-escalation Strategy in AMI Patients

NCT04755387
completednot_applicable

ST2 for the Management of Heart Failure - STADE-HF

NCT02963272
unknownnot_applicable

Substrate abLatIon as Concomitant trEatment for Left Atrial Macroreentrant Tachycardia

NCT05842499
completednot_applicable

Study on the Effect of Capacity Shock Intervention Under Goal-directed Hemodynamic Management on P-V Loop

NCT04934761
unknownnot_applicable

Conventional Versus Intentional StraTegy in Lesions With High Risk PrEdiction of Side Branch OccLusion in InterVEntion

NCT02644434
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04755387Phase 4

Ticagrelor De-escalation Strategy in AMI Patients

Recruiting
NCT02963272Not Applicable

ST2 for the Management of Heart Failure - STADE-HF

Completed
NCT05842499Not Applicable

Substrate abLatIon as Concomitant trEatment for Left Atrial Macroreentrant Tachycardia

Unknown
NCT04934761Not Applicable

Study on the Effect of Capacity Shock Intervention Under Goal-directed Hemodynamic Management on P-V Loop

Completed
NCT02644434Not Applicable

Conventional Versus Intentional StraTegy in Lesions With High Risk PrEdiction of Side Branch OccLusion in InterVEntion

Unknown
NCT02643147Phase 4

Loop Diuretic Dosage in Patients With Acute Heart Failure and Renal Failure: Conventional Versus Carbohydrate Antigen 125-guided Therapy (IMPROVE-HF)

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6